Apimeds Pharmaceuticals US, Inc (APUS) — Ownership
Institutional and insider ownership of Apimeds Pharmaceuticals US, Inc, top holders, and 13F filings.
Institutional ownership
| Year | Holders | % institutional |
|---|---|---|
| 2026 Q1 | 6 | 4.12% |
Institutional and insider ownership of Apimeds Pharmaceuticals US, Inc, top holders, and 13F filings.
Institutional ownership
| Year | Holders | % institutional |
|---|---|---|
| 2026 Q1 | 6 | 4.12% |